“…Since the CFS is a feasible and well-known frailty tool in critical care ( 2 , 22 , 23 ), our results encourage its incorporation into the ICU practice. It is also worth mentioning that differently from previous studies ( 3 , 23 ), we determined the prognostic effect of frailty on 6-month mortality, incorporating aspects related to long-COVID complications. Exploring long-term survival is relevant as recent work has indicated that frailty increases the risk of patient-centered adverse outcomes (e.g., functional disability) in COVID-19 ICU survivors after hospital discharge ( 11 ).…”